FDA Approves First New Sickle Cell Drug in 20 Years

Drug Industry Daily
A A
The FDA on Friday approved Endari, the first new drug in nearly 20 years to treat sickle cell anemia complications.

To View This Article:

Login

Subscribe To Drug Industry Daily